Return to homepagePandemic Pact

Developing Methods to Improve the Use of Information about Medicine Refills in Analyses of Electronic Health Record Data

  • Funded by Patient-Centered Outcomes Research Institute
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $353,289

  • Funder

    Patient-Centered Outcomes Research Institute

  • Principal Investigator

    PhD. Romain Neugebauer

  • Research Location

    United States of America

  • Lead Research Institution

    Kaiser Permanente Division of Research

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Patients with type 2 diabetes have a high risk of serious complications from COVID-19. In the hospital, diabetes patients with high blood sugar are more likely to have problems with multiple organs, need intense care, and even die. With this enhancement, the research team will use the methods developed in the original award to look at whether early treatment intensification to lower blood sugar or improved medication adherence can prevent or reduce the severity of COVID-19 in type 2 diabetes patients.